BMJ Rapid Recommendation: Thyroid hormone treatment for patients with subclinical hypothyroidism

Main Editor Ton Kuijpers, Trudy Bekkering, Thomas Agoritsas, Mieke Vermandere
Language en
Last Update May 15, 2019
Published Date May 15, 2019
Contact
Disclaimer

Sponsors This guideline was not funded.
Abstract

A BMJ-Rapid Recommendation on Thyroid hormone therapy for patients with subclinical hypothyroidism. Roles: Panel Chair: Mieke Vermandere Methods co-chair: Ton Kuijpers Oversight from RapidRecs executive: Thomas Agoritsas, Gordon Guyatt, Reed Siemieniuk, Per Olav Vandvik

PICOS
PICO 1.1
P: Patients with subclinical hypothyroidism ,
I: Thyroid hormone (levothyroxine mostly) ,
C: No treatment or placebo ,
O: ,

PICO 1.2
P: Patients with subclinical hypothyroidism - TRUST-trial excluded, but only used as indirect evidence for mortality, cardiovascular accidents, serious adverse events, side effects and fatigue ,
I: Thyroid hormone (levothyroxine mostly) ,
C: No treatment or placebo ,
O: ,